Kidswell Bio Revs Up Biosimilar Push, G-Lasta, Eylea Follow-Ons in Development

February 22, 2023
Masaharu Tani, President & CEO, Kidswell Bio Kidswell Bio, a Hokkaido University spinoff formerly known as Gene Techno Science, continues to ramp up its efforts on biosimilar development, advancing follow-on versions of G-Lasta (pegfilgrastim) and Eylea (aflibercept) through its pipeline,...read more